Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Pricing
SKY Learn

Sector: Pharmaceuticals & Biotechnology

Small Cap

Mangalam Drugs Share Price

Q: What is the current share price of Mangalam Drugs and Organics Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Mangalam Drugs and Organics Ltd. is ₹ 28.5 on the NSE and ₹ 29.09 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Mangalam Drugs and Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mangalam Drugs and Organics Ltd. is approximately ₹ 43 Cr.

Q: What are the PE and PB ratios for Mangalam Drugs and Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mangalam Drugs and Organics Ltd. is -1.4, and the Price-to-Book (PB) ratio is 0.4.

Q: What is the 52-Week High and Low for Mangalam Drugs and Organics Ltd.?

Over the past 52 weeks, the highest price reached by Mangalam Drugs and Organics Ltd. shares was ₹ 95, and the lowest price was ₹ 22.8.

Q: Who are the major shareholders of Mangalam Drugs and Organics Ltd.?

Significant shareholdings in Mangalam Drugs and Organics Ltd. typically include entities such as: Public Promoter FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Mangalam Drugs and Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mangalam Drugs and Organics Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Q: What is the latest dividend information for Mangalam Drugs and Organics Ltd.?

Mangalam Drugs and Organics Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2017. The record date was set as 2017-12-21, and the payment was/is scheduled around 2017-12-21. For the most current dividend announcements, refer to official company filings.

Mangalam Drugs and Organics Ltd.

₹28.50

1.35(4.97%)

Trade Now

1st Apr 2026 | 11:52 AM

NSE : MANGALAM

Open Free Demat Account

Mangalam Drugs Performance

Price Movement

₹28.50

₹26.51

₹28.50

↘ Today's Low↗ Today's High

1 Year Performance

₹28.50

₹22.80

₹95.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹28.50

Low₹26.51

Open at₹26.51

Prev Close₹27.15

Volumes23.71 K

Avg Price₹27.99

Lower Circuit₹25.80

Upper Circuit₹28.50

Historical Performance

3M High₹54.40

3M Low₹26.54

1 Yr High₹95.00

1 Yr Low₹22.80

3 Yr High₹144.99

3 Yr Low₹22.80

5 Yr High₹196.95

5 Yr Low₹22.80

Mangalam Drugs Fundamentals

Market Cap

Low in industry

43 Cr.

PE Ratio (TTM)

Negative PE TTM

-1.40

Dividend Yield

Net Profit TTM

403% decr over last year

-30.92

Net Profit Growth

403% decr over last year

-30.92

PEG Ratio

Below industry Median

ROE

167.5% incr over last year

4.51

Operating Revenue TTM

238.42

Operating Revenue Growth

31% decr over last year

Book Value

Low in industry

0.40

MFI

MFI is mid-range

36.63

RSI

RSI is mid-range

33.76

EPS (TTM)

4.25

Debt to Equity

0.54

Face Value

Operating Profit Margin Qtr.

11.24

Operating Profit Qtr.

-1.43

Net Profit Qtr.

-9.84

Operating Revenue Qtr.

58.49

PB Ratio

0.40

Mangalam Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	58.49	49.54	57.35	73.04	88.71
Operating Expense	59.96	52.38	61.85	62.88	79.94
Operating Profit	-1.47	-2.83	-4.50	10.15	8.77
Depreciation	4.37	4.53	4.38	4.61	3.93
Interest	4.05	5.03	4.04	4.03	3.49
Tax	0	-5.12	0.80	1.58	0.08
Net Profit	-9.78	-7.25	-13.73	0.15	1.40

Mangalam Drugs Technicals

Mangalam Drugs and Organics Ltd. EMA & SMA

₹28.50

0.05 (0.18%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹28.6

Day EMA10 ₹29.4

Day EMA12 ₹29.6

Day EMA20 ₹30.3

Day EMA26 ₹30.8

Day EMA50 ₹32.9

Day EMA100 ₹39.4

Day EMA200 ₹52.6

Mangalam Drugs Support and Resistance

Resistance

First Resistance₹28.16

Second Resistance₹29.16

Third Resistance₹29.73

Support

First Support₹26.59

Second Support₹26.02

Third Support₹25.02

Technical Indicators

Day RSI33.76

Day MFI36.63

Day ADX28.22

Day Commodity Channel Index-156.70

William-98.57

Day MACD-1.20

Day MACD Signal Line-1.03

Day ATR1.84

Day ROC125-63.35

Day ROC21-7.02

Mangalam Drugs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	50.3	50.3	50.3	50.3	50.3	35.6
FII	0.1	0.1	0.5	0.5	0.1	0.1
DII	0	0	0	0	0	0
Public	49.6	49.6	49.2	49.2	49.6	64.2

Mangalam Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	37.65 K	37.65 K	100.00%
Week	42.31 K	42.31 K	100.00%
1 Month	61.48 K	64.84 K	94.82%
6 Month	1.41 L	1.78 L	79.28%

Mangalam Drugs SWOT Analysis

Strengths8

Weakness14

Opportunity1

Threats2

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Companies with decreasing Promoter pledge

Stock with Low PE (PE < = 10)

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Mangalam Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
21 Dec, 2017	0.5	INTERIM	22 Dec, 2017	Equity Share
19 Sep, 2006	0.2	FINAL		Equity Share
30 Aug, 2005	0.2	FINAL		Equity Share

Mangalam Drugs Stock Comparison

Financials	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.	Influx Healthtech Ltd.
Price (₹)	₹5.54	₹99.90	₹101.40	₹114.80	₹16.50	₹214
% Change	4.92%	7.48%	1.59%	3.07%	0.00%	5.94%
Revenue TTM (₹ Cr)	₹83.60	-	₹282.74	-	-	-
Net Profit TTM (₹ Cr)	₹-34.95	-	₹15.30	-	-	-
PE TTM	-1.30	12.30	25.30	-	5.70	35.00
1 Year Return	428	-27.38	-20.79	22.4	-61.63	110.42
ROCE	-5.63	-	-	-	-	-

Similar Stocks

MEDIORG

Medicamen Organics Ltd.

₹ 22.15

+4.98%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 504.00

+2.10%

SENORES

Senores Pharmaceuticals Ltd.

₹ 780.00

+2.69%

INNOVACAP

Innova Captab Ltd.

₹ 707.25

+2.52%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.45

+11.29%

SUPRIYA

Supriya Lifescience Ltd.

₹ 606.50

+7.94%

SIGACHI

Sigachi Industries Ltd.

₹ 18.89

+11.64%

WINDLAS

Windlas Biotech Ltd.

₹ 774.05

+5.06%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.74

+2.34%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 460.00

+8.10%

ZIMLAB

Zim Laboratories Ltd.

₹ 63.72

+5.74%

MEDICO

Medico Remedies Ltd.

₹ 38.11

+16.33%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 142.45

+9.60%

LASA

Lasa Supergenerics Ltd.

₹ 5.95

+4.94%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 268.95

+5.35%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 312.80

+7.82%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.23

+4.94%

BROOKS

Brooks Laboratories Ltd.

₹ 44.53

+19.99%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1914.60

+3.06%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 114.80

+4.99%

ALPA

Alpa Laboratories Ltd.

₹ 50.26

+8.18%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 119.53

+4.04%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 391.90

+4.55%

NECLIFE

Nectar Lifesciences Ltd.

₹ 9.76

+4.95%

FAQ's on MANGALAM

What is the current share price of Mangalam Drugs and Organics Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Mangalam Drugs and Organics Ltd. is ₹ 28.5 on the NSE and ₹ 29.09 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Mangalam Drugs and Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mangalam Drugs and Organics Ltd. is approximately ₹ 43 Cr.

What are the PE and PB ratios for Mangalam Drugs and Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mangalam Drugs and Organics Ltd. is -1.4, and the Price-to-Book (PB) ratio is 0.4.

What is the 52-Week High and Low for Mangalam Drugs and Organics Ltd.?

Over the past 52 weeks, the highest price reached by Mangalam Drugs and Organics Ltd. shares was ₹ 95, and the lowest price was ₹ 22.8.

Who are the major shareholders of Mangalam Drugs and Organics Ltd.?

Significant shareholdings in Mangalam Drugs and Organics Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Mangalam Drugs and Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mangalam Drugs and Organics Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

What is the latest dividend information for Mangalam Drugs and Organics Ltd.?

Mangalam Drugs and Organics Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2017. The record date was set as 2017-12-21, and the payment was/is scheduled around 2017-12-21. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy